In a recent corporate filing, C-MER Eye Care Holdings Limited (03309) disclosed its execution of a share repurchase transaction on July 15, 2025. The Hong Kong-listed ophthalmic services provider acquired 150,000 of its own shares through open market operations. The aggregate consideration for this repurchase amounted to HK$266,000, reflecting the company's ongoing capital management strategy. This move represents the latest in a series of share buybacks undertaken by the healthcare group throughout the current fiscal year. Market observers note such repurchases typically signal management's confidence in the company's fundamental valuation and long-term growth trajectory. The transaction was conducted during normal trading hours on the Hong Kong Stock Exchange under prevailing market conditions. Corporate filings indicate the repurchased shares will be held in treasury for potential future reissuance or cancellation, subject to regulatory approvals and shareholder authorization. This capital allocation decision comes amid broader market volatility in the healthcare services sector across the Asia-Pacific region.